The complexity and extended life cycles of existing animal models have hindered the study of Parkinson's disease during its preclinical stages. Now, a research team led by the Institut de ...

Researchers from the Cleveland Clinic Genome Center have successfully applied advanced artificial intelligence (AI) genetics ...

U.S. Department of Defense awards $4 million to researchers at OHSU, University of Washington, VA Portland, VA Puget Sound to ...

Researchers from the Champalimaud Foundation have shed light on the puzzling relationship between dopamine and rest tremor in Parkinson's disease ... to test this in animal models, where we ...

Rates of Parkinson’s disease are rising for reasons which ... What we see in our animal models is that we have a very fascinating molecule with all these effects that we're after, and now ...

CBE is an irreversible GCase inhibitor, and its addition to a PFF can therefore serve as a model for GBA-1 Parkinson’s disease. Another animal model of PD is the rotenone model. The nGD model is ...

Innovative treatment for Parkinson's disease: microscopic particles combined with light therapy offer a non-surgical solution ...

A novel wireless photothermal DBS nanosystem uses nanoparticles to target and restore damaged neurons in Parkinson’s disease, ...

By contrast, in animal models of Parkinson's disease, nicotine alone has slight or no motor effects. However, nicotine may modulate dopamine transmission and has clear motor effects when ...

Catching and treating Parkinson's disease early is crucial ... However, treating the Parkinson's-model mice with PNA5 appeared to lower the animals' blood levels of the inflammatory chemical.